Description
Benefits
- Supports sleep maintenance and reduces nighttime awakenings
- Helps improve overall sleep continuity and duration
- Targets histamine-mediated arousal rather than broad sedation
- Minimal impact on next-day alertness at low doses
- Supports overnight recovery, hormonal balance, and metabolic health
- Commonly used in longevity and performance-recovery protocols
Background and History
- Sleep fragmentation has been identified as a major contributor to metabolic dysfunction and accelerated aging
- Doxepin was originally developed as an antidepressant and later studied for its sleep-specific effects at low doses
- Low-dose formulations were found to selectively target histamine receptors involved in nighttime wakefulness
- This mechanism distinguished it from traditional sedative sleep medications
- Longevity medicine increasingly favors agents that support sleep architecture rather than blunt CNS activity
- Doxepin became widely used in protocols focused on sustained, restorative sleep and long-term health
Compounded, non-FDA-approved medication. Individual results may vary.
